PacBio’s mission is to enable the promise of genomics to better human health.
We create some of the world’s most advanced sequencing technologies to provide scientists and clinical researchers the insights to better understand biology and health.
Our products and technology stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our existing HiFi long read sequencing technology and our emerging short read Sequencing by Binding (SBB®) technology. Our products address solutions across a broad set of applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
PacBio to Present at Upcoming Investor Conferences
November 9, 2023
Recent and Upcoming Events
Piper Sandler 35th Annual Healthcare Conference
November 28, 2023
at 3:00 PM EST
Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
November 16, 2023
at 2:00 PM EST
Pacific Biosciences of California, Inc. Third Quarter 2023 Earnings Conference Call
October 30, 2023
at 4:30 PM EDT
Morgan Stanley 21st Annual Global Healthcare Conference
September 12, 2023
at 12:55 PM EDT